Immunotherapy side effect could be a positive sign for kidney cancer patients

(UT Southwestern Medical Center) An autoimmune side effect of immune checkpoint inhibitor (ICI) drugs could signal improved control of kidney cancer, according to a new study by researchers in UT Southwestern's Kidney Cancer Program (KCP).